• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Aspivix's Carevix Cervical Stabilizer Gains FDA OK

    Apyx Medical Submits 510(k) App for Renuvion APR Handpiece

    LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy

    CGM Devices Could Become Main Glucose Monitoring Solution in U.S.

    New Device Developed to Non-Invasively Measure Cervical Nerve Activity
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Providence Enterprise USA Inc.

    Medbio LLC

    Arthur G. Russell Co. Inc., The

    Forefront Medical Technology
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Providence Enterprise USA Inc.

    Medbio LLC

    Arthur G. Russell Co. Inc., The

    Forefront Medical Technology
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    Deadline: March 2019—Don’t Get Shutout of Europe

    OEMs need to recognize if their suppliers will achieve EN ISO 13485:2016 certification in time.

    Deadline: March 2019—Don’t Get Shutout of Europe
    FMI carried out a gap analysis back in January 2017, and is planning to inspect its compliance to EN ISO 13485 in April 2018. Image courtesy of Flexan.
    Deadline: March 2019—Don’t Get Shutout of Europe
    The advantage of process FMEAs is that potential error sources are identified before the actual production and countermeasures can be taken as early as possible in the process chain. This prevents any faulty products being delivered. Image courtesy of Flexan.
    Deadline: March 2019—Don’t Get Shutout of Europe
    To satisfy the growing quality demands, FMI has, for example, optimized its risk management for product realization and its CAPA program. Image courtesy of Flexan.
    Related Content
    • MEDICAL & BIOTECH MANUFACTURING
    • Flexan LLC
    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    • Accu-Tube Appoints Matthew Haddle as CEO
    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    Leo Gelera, Quality Manager, FMI12.21.17
    Medical device manufacturers are responsible for ensuring that all components, even those produced externally, comply with all relevant ISO guidelines. To this end, they must verify the quality management systems of their suppliers fulfill all the necessary requirements. This is all the more urgent now as two crucial standards have recently been revised. Suppliers must ensure their processes conform to the new EN ISO 9001 by September 2018 and to the revised EN ISO 13485 by March 2019. If a component manufacturer doesn’t obtain certification in time, the OEM will have to switch suppliers, at least in the short term. If this is not an option, the worst-case scenario means the manufacturer will be unable to market their product in Europe.
     
    For OEMs, it is not always easy to ensure that vendor parts conform to ISO standards. In the best-case scenario, the quality management systems of a firm’s suppliers are efficient enough to recognize risks and prevent faults and defects. The medical device manufacturer recognizes how effective the internal processes are using factors such as certification per ISO standards, risk management for product realization, the use of a Corrective and Preventive Actions (CAPA) program, and the significance of quality as part of the corporate culture.
     
    Certification According to the Revised Standards Is Essential
    As both EN ISO 9001, which specifies the minimum requirements on QM systems, and EN ISO 13485 have been recently revised, the priority for OEMs at the moment is to ensure that suppliers comply with the deadlines for certifications according to these revised standards. The key objective of the new standards is to improve the risk management among suppliers of the medical industry. Among other things, this is accomplished with a more intensive focus on the need for controls throughout the entire supplier process chain.
     
    In order to complete the certification process successfully within the deadline, the supplier can engage an external consultant or use internal personnel resources. If the latter approach is chosen, the office responsible for the certification should be contacted. This office will provide advice on the best process and provide the checklists, which are also used for later evaluation. In addition, the quality manager responsible for the project should attend a training session about the requirements of the new standards and be certified as the lead auditor. If this occurs, the next step is to carry out a gap analysis. In doing so, the requirements of the new guidelines are compared with the current processes at the supplier’s premises and steps for their adjustment are identified.
     
    Pressing Deadline
    The companies should not dawdle. The regulatory bodies are allowing the exact amount of time required for successful certification between the publication of the standard and the end of the deadline. By September 2017, for example, the gap analysis should have been performed and a precise plan for the upgrade should have been developed as well. The key elements of ISO 13485:2016 are the training and CAPA program along with more accurate supplier checks.
     
    There can be grave consequences for an OEM if it obtains components from a supplier that has a quality management system not certified in accordance with ISO 13485:2016. This certification is a fundamental prerequisite for being able to market a medical device in the European Union. As a result, it is one of the standard requirements of suppliers for many OEMs. If the deadline is not complied with, the medical device manufacturer must not use these components in its production processes until the non-compliance is resolved. As OEMs normally only have one supplier for a specific component, there is the risk that existing orders might not be fulfilled. If the medical device manufacturer has the impression that its supplier is not currently far enough into the certification process, the OEM should at least request the supplier’s action plan and schedule for the adjustments in order to get a more accurate overview and be able to take action in good time.
     
    Related Questions and Answers
    Following is a brief Q&A that further addresses common questions related to this topic that should be of interest to medical device manufacturers or, at the very least, encourage a discussion between an OEM and its supply chain partners.
     
    Q: ISO certification is just one factor that provides OEMs with information about how good the quality management of a supplier is. What about the implementation of risk management processes into product realization?
    A: In the ISO standards in question, suppliers are required to implement risk management processes into the field of product realization. However, what these processes should look like exactly is kept deliberately vague. As a result, companies have more creative leeway and can take the most effective measures. Naturally, this is connected with a continual learning process, which can still be accelerated a little—for example, through comparison with the process of similar suppliers. Typical questions are:
     
    • What risk management tools are used?
    • Are risk management practices used during the entire production process?
    • How efficient are these?
     
    The answers to these questions also provide OEMs with information for their appraisal of supplier processes. FMI, for example, has incorporated various processes over the entire product realization stage, including various Failure Mode and Effects Analyses (FMEAs), part-specific control plans and operating instructions, error recognition in each process, dimensional checks, and FAQL and Final Lot Release Inspections. The implementation of process FMEAs is particularly recommended. Their advantage is that potential error sources are identified before the actual production and countermeasures can be taken as early as possible in the process chain. This prevents any faulty products being delivered.
     
    Q: How important are CAPA programs?
    A: Having an efficient CAPA system is ultimately essential for any company and any organization. CAPA are generally triggered when an error occurs, whether internally or externally. Its purpose is to understand the cause, the scope, and the effects of the incident. In the best-case scenario, it can help to correct arising errors and specify measures that will prevent a reoccurrence of the fault or defect in the future. Subsequently, the effectiveness of the countermeasure should also be checked. If such an analysis including the derived measures is not carried out, there is the risk the error will reoccur repeatedly.
     
    Q: What role must quality play as part of the corporate culture?
    A: The aim of a supplier must ultimately be to make collaboration with the OEM as simple and low maintenance as possible. Preferably, the supplier shouldn’t even appear on the radar of the medical device manufacturer because its quality performance is flawless. This is where the “quality culture” is crucial for a supplier. Every employee must understand the central role he or she plays in quality and what far-reaching consequences there can be if just one component is defective. Within the industry, many components are manufactured that later contribute to saving or preserving human life. Employees should be given precise information about the significance of a component and how much depends on it functioning accurately. This also enhances an employee’s appreciation of their own work.
     

    Leo Gelera is the quality manager at FMI, a business unit of Flexan LLC. Founded in 1946, Flexan LLC is a global manufacturer of high-precision elastomer parts for a wide range of industry applications. It operates out of four manufacturing facilities with about 800 employees. Its Flexan unit focuses on custom molding while its FMI business delivers cleanroom-manufactured silicone rubber components for use in Class II disposable and Class III implantable medical devices. High-volume custom molded elastomer and cleanroom silicone rubber is offered from the Flexan-Suzhou factory. Flexan’s MEDRON division serves a wide range of outsourcing capabilities, including high volume manufacturing, customer private label capability, design engineering, product development, and prototyping. MEDRON's expertise comprises a wide range of materials, including medical grade urethanes and engineering thermoplastics. The firm is owned by Linden Capital Partners, a Chicago-based private equity firm focused exclusively on leveraged buyouts in the healthcare and life sciences industries.
    Related Searches
    • medical device manufacturers
    • implantable
    • ul
    • it
    Related Knowledge Center
    • Molding
    • Machining & Laser Processing
    • Contract Manufacturing
    Suggested For You
    MEDICAL & BIOTECH MANUFACTURING MEDICAL & BIOTECH MANUFACTURING
    Flexan LLC Flexan LLC
    Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles
    Accu-Tube Appoints Matthew Haddle as CEO Accu-Tube Appoints Matthew Haddle as CEO
    Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings
    CE Mark Granted to Predictive Software for Kidney Allograft Survival CE Mark Granted to Predictive Software for Kidney Allograft Survival
    Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech Electroducer Raises 3 Million Euros to Market Heart Valve Disease Tech
    Precision Coating Merges with N2 Biomedical Precision Coating Merges with N2 Biomedical
    Medical Devices Market to Top $671.49 Billion by 2027 Medical Devices Market to Top $671.49 Billion by 2027
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    Molli Surgical Molli Surgical's Breast Tumor Marker
    Vertigo Treatment Receives FDA Breakthrough Device Designation Vertigo Treatment Receives FDA Breakthrough Device Designation
    RapidPulse Closes $15 Million Series A Financing RapidPulse Closes $15 Million Series A Financing
    Midwest Products & Engineering Acquires MindFlow Design Midwest Products & Engineering Acquires MindFlow Design
    Vicarious Surgical Opens New Corporate Headquarters in Massachusetts Vicarious Surgical Opens New Corporate Headquarters in Massachusetts

    Related Literature / Brochures

    • MEDICAL & BIOTECH MANUFACTURING

      ISO 13485:2016 • FDA Registered

    • Flexan LLC

      ...
      Mike Huiras 11.21.22

    • Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Hyperfine Names Paykel, Teisseyre to Executive Leadership Roles

      Neela Paykel is serving as general counsel and Tom Teisseyre assumes the chief product officer position.
      Business Wire 09.22.21


    • Tubing & Extrusion
      Accu-Tube Appoints Matthew Haddle as CEO

      Accu-Tube Appoints Matthew Haddle as CEO

      Haddle has a track record of leading organizations through strategic expansions across the medical device, aerospace, and industrial sectors.
      Accu-Tube 09.22.21

    • Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

      The two deals will strengthen Heraeus' healthcare and medtech portfolio.
      Heraeus 09.22.21

    Loading, Please Wait..

    Trending
    • Study: Smartphone Therapeutic Helps Improve Fibromyalgia In Patients
    • The Future Of Biomedical Engineering Advancements
    • Environmental Sustainability Becoming Increasingly Important To Medtech Industry
    • Medtronic's Recall Of Mahurkar Catheters Is Class I
    • A New Approach To Post-Market Surveillance
    Breaking News
    • Aspivix's Carevix Cervical Stabilizer Gains FDA OK
    • Apyx Medical Submits 510(k) App for Renuvion APR Handpiece
    • LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    • CGM Devices Could Become Main Glucose Monitoring Solution in U.S.
    • New Device Developed to Non-Invasively Measure Cervical Nerve Activity
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    GOED Elects New Board Officers for 2023
    Aspire Hires Darrec Jones as VP of Business Development
    Pycnogenol Supplementation Linked to Better Hair Density in Menopausal Women
    Coatings World

    Latest Breaking News From Coatings World

    PPG Completes COLORFUL COMMUNITIES Project in Denmark
    10 Partners of the Automotive Industry Form JV, Cofinity-X
    BASF Recognized as Top Company for Supplier Diversity
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    LivaNova Releases SenTiva DUO VNS for Drug-Resistant Epilepsy
    CGM Devices Could Become Main Glucose Monitoring Solution in U.S.
    New Device Developed to Non-Invasively Measure Cervical Nerve Activity
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Bionova Expansion Project to Quadruple GMP Biologics Manufacturing Capacity
    Steriline Provides Fill-Finish Solution for Berkshire Sterile Manufacturing
    Merck Revenues up 22% for the Year to $59.3B
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Kering Appoints Former L’Oréal and Estée Lauder Exec as CEO of Kering Beauté
    Paco Rabanne, Fashion & Perfume Designer, Dies
    Lush Supports Cancer Research with New Bath Bomb
    Happi

    Latest Breaking News From Happi

    Elf Cosmetics Launches New O Face Satin Lipstick
    IFF Appoints Gary Hu to Board of Directors
    Paco Rabanne Dies at 88
    Ink World

    Latest Breaking News From Ink World

    Roland DGA Announces Key Changes to Leadership Team
    Ball Reports 2022 Results
    3D Printing Materials Market Worth $7.9 Billion by 2027: MarketsandMarkets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Cepi, EHPA partner for energy savings in paper manufacturing
    Brook + Whittle acquires LLT Labels
    ABG adds laser perforation to shrink sleeve seaming solution
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Qvin Menstrual Blood Diagnostic Device Receives FDA Approval in Thailand
    Andritz, KCF Technologies Form Agreement
    Freudenberg e-Power Systems, LG Energy Solution Announce Partnership
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Toetal Solutions Secures $1.8 Million in New Financing
    Adrian Tyndall Joins Axogen's Board of Directors
    ADSM-Synchro Medical Acquired by Tyber Medical
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Zebra Provides East West Shrine Bowl with RFID Tracking Technology
    AAAS Elects Three ORNL Scientists as Fellows
    Flex Recognized as One of Fortune World’s Most Admired Companies 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login